hemagglutinin
protein
h
one
two
glycoprotein
pest
de
petit
rumin
viru
pprv
bind
receptor
host
cell
act
major
antigen
induc
confer
highli
protect
immun
host
order
delin
epitop
h
protein
fine
epitop
map
conserv
analysi
linear
bcell
epitop
bce
pprv
h
undertaken
use
biosynthet
peptid
rabbit
antipprv
h
sera
thirteen
linear
bce
identifi
correspond
minim
motif
locat
h
protein
pprv
conserv
analysi
indic
two
minim
motif
conserv
among
pprv
strain
nine
peptid
contain
minim
motif
recogn
use
antipprv
serum
goat
immun
pprv
vaccin
strain
nigeria
identifi
epitop
motif
improv
understand
antigen
characterist
pprv
h
provid
basi
develop
epitopebas
diagnost
assay
multipl
epitop
vaccin
pest
de
petit
rumin
ppr
highli
infecti
diseas
domest
wild
small
rumin
caus
ppr
viru
pprv
member
genu
morbilliviru
includ
rinderpest
viru
rpv
measl
viru
mev
canin
distemp
viru
cdv
phocin
distemp
viru
pdv
cetacean
morbilliviru
cemv
felin
morbilliviru
femv
torsson
et
al
clinic
symptom
associ
ppr
includ
pyrexia
congest
mucos
surfac
ocular
nasal
discharg
eros
stomat
diarrhea
liang
et
al
libeau
notifi
diseas
list
world
organ
anim
health
oie
ppr
signific
socioeconom
impact
poverti
allevi
develop
countri
oie
togeth
food
agricultur
organ
fao
launch
control
erad
strategi
aim
global
elimin
diseas
pprv
classifi
four
lineag
base
partial
sequenc
nucleocapsid
n
fusion
f
gene
even
though
viru
serolog
monotyp
recent
lineag
associ
geograph
distribut
viru
lineag
ii
iii
common
africa
lineag
iv
middl
east
asia
adombi
et
al
santhamani
et
al
howev
last
decad
lineag
iv
virus
regularli
report
differ
african
countri
appear
spread
effici
within
contin
adombi
et
al
nonseg
singlestrand
negativesens
rna
genom
pprv
encod
six
structur
two
three
nonstructur
protein
order
baron
among
three
viral
protein
n
h
f
abl
induc
immun
respons
two
surfac
glycoprotein
h
f
stimul
neutral
protect
antibodi
product
host
target
develop
recombin
vaccin
use
confer
protect
goat
recombin
protein
report
confer
immun
express
either
togeth
separ
libeau
liu
et
al
lymphocyt
play
fundament
role
protect
host
invad
pathogen
confer
celland
antibodymedi
immun
respons
follow
stimul
pathogen
b
cell
lymphocyt
secret
neutral
antibodi
highli
effect
clear
foreign
invad
pprv
munir
et
al
therefor
map
b
cell
epitop
bce
viral
protein
prerequisit
design
effici
recombin
multiepitop
vaccin
furthermor
identif
epitop
domain
pprv
structur
protein
facilit
develop
epidemiolog
surveil
method
monitor
immun
statu
anim
bce
map
also
help
advanc
diva
differenti
infect
versu
vaccin
anim
strategi
bce
categor
either
linear
compos
continu
amino
acid
aa
conform
discontinu
aa
natur
major
bce
discontinu
due
difficulti
map
design
epitop
research
center
linear
bce
han
et
al
although
effort
requir
identifi
epitop
viral
protein
sever
report
describ
antigen
region
pprv
h
n
protein
choi
et
al
dechamma
et
al
renukaradhya
et
al
employ
four
differ
monoclon
antibodi
delet
mutant
pprv
h
express
escherichia
coli
mammalian
cell
renukaradhya
et
al
b
cell
epitop
region
neutral
antibodi
bind
capac
map
two
region
pprv
h
protein
aa
aa
howev
report
indepth
map
minim
motif
identif
bce
associ
pprv
h
protein
anoth
conveni
highli
effici
method
epitop
screen
adopt
fine
map
epitop
coronaviru
protein
hua
et
al
sun
et
al
iggepitom
decod
protein
oncogen
human
papillomaviru
type
xu
et
al
involv
use
biosynthet
peptid
biosynthet
peptid
polyclon
serum
pprv
n
protein
employ
previou
studi
fine
epitop
map
conserv
analysi
linear
bcell
epitop
pprv
n
protein
yu
et
al
strategi
adopt
identifi
linear
epitop
minim
motif
pprv
h
protein
data
increas
knowledg
bce
distribut
pprv
h
protein
provid
solid
foundat
ration
design
multiepitop
base
vaccin
diagnost
antigen
recombin
h
protein
pprv
employ
immun
antigen
prepar
describ
previous
xu
et
al
zhang
et
al
pprv
preval
strain
china
research
initi
first
ppr
viru
genom
sequenc
china
briefli
codon
optim
h
gene
pprv
synthes
clone
prokaryot
express
vector
express
e
coli
separ
gene
product
use
sdspage
purif
electroelut
excis
gel
band
protein
concentr
peg
store
prior
use
immunogen
four
femal
new
zealand
white
rabbit
kg
bodi
weight
purchas
shanghai
slac
laboratori
anim
co
ltd
shanghai
china
maintain
accord
standard
laboratori
anim
care
protocol
approv
institut
anim
care
committe
saa
three
rabbit
inject
intramuscularli
mg
purifi
recombin
h
protein
emulsifi
complet
freund
adjuv
cfa
sigma
aldrich
san
francisco
usa
multipl
site
back
anim
three
booster
inject
mg
antigen
per
inject
incomplet
freund
adjuv
administ
twoweek
interv
anim
bled
day
third
booster
serum
separ
store
use
antibodi
titer
combin
sera
three
immun
rabbit
design
determin
elisa
previous
describ
except
coat
antigen
replac
pprv
h
protein
zhang
et
al
nonimmun
serum
remain
one
rabbit
receiv
cfa
use
neg
control
use
truncat
glutathion
stransferas
initi
aa
design
carrier
peptid
one
peptid
overlap
aa
residu
cover
entir
h
protein
pprv
express
fusion
protein
describ
earlier
yu
et
al
addit
seri
overlap
peptid
aa
residu
overlap
posit
identifi
later
ie
similarli
express
briefli
synthes
anneal
dna
fragment
encod
short
peptid
incorpor
bamh
taasal
cohes
end
respect
insert
bamh
sal
site
plasmid
e
coli
plyss
employ
express
fusion
peptid
posit
clone
select
sdspage
confirm
dna
sequenc
cell
pellet
contain
fusion
peptid
store
bce
map
western
blot
sdspage
western
blot
perform
previous
describ
yu
et
al
minor
modif
briefli
cell
pellet
resolv
sdspage
use
gel
gel
either
stain
coomassi
brilliant
blue
confirm
band
fusion
protein
process
western
blot
electrotransf
protein
onto
nitrocellulos
membran
whatman
gmbh
dossel
germani
membran
block
wv
skim
milk
powder
phosphatebuff
salin
pb
incub
sequenti
dilut
goat
antirabbit
igg
conjug
horseradish
peroxidas
dilut
protein
tech
group
inc
chicago
usa
visual
enhanc
chemiluminesc
use
ecl
plu
western
blot
detect
reagent
ge
healthcar
chalfont
st
gile
uk
accord
manufactur
instruct
search
protein
databank
archiv
rcsb
pdb
http
www
rcsborgpdbhomehomedo
reveal
structur
pprv
h
protein
structur
ntermin
cytoplasm
tail
aa
stalk
region
aa
ctermin
receptorbind
head
domain
aa
pprv
h
protein
predict
use
protein
homologyanalog
recognit
engin
v
kelley
et
al
server
http
cgi
idindex
intens
model
mode
fulllength
aa
sequenc
h
protein
pprv
strain
avail
genbank
align
use
softwar
analysi
bcecontain
sequenc
pprv
h
perform
mega
softwar
version
initi
antigen
region
contain
linear
bce
broadli
delin
use
seri
longer
peptid
fragment
cover
entir
pprv
h
protein
rabbit
polyclon
antiserum
seventyfour
overlap
fragment
singl
fragment
fusion
express
e
coli
fusion
protein
observ
approxim
kda
band
sdspage
fig
among
express
product
follow
peptid
identifi
posit
western
blot
fig
six
sequenc
locat
aminoterminu
half
h
protein
aa
fig
remain
eight
posit
sequenc
locat
closer
carboxyl
terminu
aa
fig
fourteen
set
overlap
peptid
fusion
express
e
coli
antiserum
use
second
round
fine
epitop
character
posit
peptid
identifi
first
round
within
everi
set
except
one
six
stain
antiserum
share
aa
aa
aa
aa
fig
share
amino
acid
tent
design
minim
epitop
motif
sinc
set
yield
posit
two
set
nest
polypeptid
larger
synthes
one
minim
motif
subsequ
identifi
see
easi
descript
two
neighbor
share
motif
case
motif
assign
latter
peptid
consequ
minim
bind
motif
pprv
h
protein
ascrib
residu
ina
sinc
fail
react
set
two
serial
peptid
one
amino
acid
subtract
progress
either
cor
nterminu
fusion
express
e
coli
use
identifi
minim
bind
motif
peptid
shown
fig
react
fusion
express
serial
peptid
fig
amino
acid
residu
respect
delet
ctermin
end
peptid
one
amino
acid
residu
subtract
ntermin
end
therefor
conclud
one
minim
epitop
motif
iigdevgiri
exist
peptid
fig
clarifi
spatial
locat
minim
motif
bce
identifi
pprv
h
protein
structur
model
ntermin
cytoplasm
tail
aa
stalk
region
aa
ctermin
head
domain
aa
protein
gener
use
server
data
predict
residu
constitut
head
domain
model
confid
remain
residu
model
ab
initio
howev
none
residu
compris
cytoplam
tail
stalk
region
model
confid
level
posit
map
bce
motif
structur
reveal
distribut
region
predict
loop
helix
fig
eleven
motif
expos
partial
expos
surfac
predict
structur
fig
suggest
antibodyaccess
wherea
remain
two
motif
epitop
motif
fig
almost
entir
buri
insid
pprv
h
protein
comparison
avail
pprv
h
protein
sequenc
indic
two
bce
motif
fulli
conserv
ie
seventyfour
peptid
one
peptid
cover
entir
h
protein
pprv
express
e
coli
strain
induct
cell
harvest
centrifug
cell
pellet
resolv
sdspage
use
gel
gel
either
stain
process
western
blot
nitrocellulos
membran
first
block
wv
skim
milk
incub
sequenti
dilut
goat
antirabbit
igg
dilut
visual
enhanc
chemiluminesc
c
e
sdspage
analysi
gst
fusion
express
one
b
f
western
blot
analysi
gst
fusion
express
one
gst
fusion
express
peptid
denot
posit
gst
fusion
express
r
yu
et
al
veterinari
microbiolog
fig
determin
minim
motif
identifi
bce
western
blot
similar
short
peptid
pprv
h
protein
express
e
coli
strain
induct
cell
harvest
centrifug
cell
pellet
resolv
sdspage
use
gel
gel
either
stain
process
western
blot
nitrocellulos
membran
first
block
wv
skim
milk
incub
sequenti
dilut
goat
antirabbit
igg
dilut
visual
enhanc
chemiluminesc
hyphen
number
repres
sequenti
number
express
peptid
use
screen
minim
motif
posit
nine
select
contain
one
identifi
minim
motif
sequenc
recogn
western
blot
use
antipprv
serum
dilut
goat
immun
pprv
vaccin
strain
nigeria
primari
antibodi
fig
nine
bce
motif
predict
locat
partial
locat
surfac
h
protein
react
goatantipprv
serum
albeit
weakli
case
epitop
fig
remain
two
epitop
fig
situat
within
cytoplasm
tail
stalk
region
respect
among
nine
bce
motif
recogn
antipprv
serum
epitop
fig
epitop
fig
elicit
stronger
antibodi
respons
infect
occur
envelop
virus
must
first
interact
membran
protein
receptor
surfac
host
cell
induc
fusion
viral
membran
host
cell
membran
pprv
h
protein
bind
cognat
receptor
host
cell
first
step
viral
infect
process
act
major
antigen
stimul
protect
immun
respons
host
renukaradhya
shaila
pprv
h
protein
also
shown
effect
induc
humor
cellmedi
immun
respons
recombin
vector
virus
express
h
alon
combin
f
anoth
pprv
glycoprotein
induc
high
level
antibodi
protect
goat
sheep
experiment
challeng
pathogen
pprv
caufour
et
al
holzer
et
al
howev
multiepitop
base
recombin
vaccin
offer
numer
advantag
compar
complet
protein
includ
costeffect
product
multival
stabil
differ
condit
moreov
efficaci
epitop
vaccin
improv
combin
helper
promiscu
epitop
employ
epitop
enhanc
techniqu
immuneinformat
comput
immunolog
adopt
tolllik
receptor
tlr
ligand
adjuv
nezafat
et
al
rosa
et
al
consequ
order
enabl
ration
multiepitop
vaccin
diagnost
antigen
design
imper
delin
bce
target
antigen
although
shaila
cowork
identifi
two
discontinu
b
cell
epitop
region
aa
three
region
includ
cell
determin
aa
pprv
h
protein
renukaradhya
et
al
sinnathambi
et
al
sinnathambi
et
al
total
number
bce
tce
precis
natur
locat
minim
motif
still
need
determin
continu
fine
epitop
map
linear
bce
pprv
n
protein
yu
et
al
carri
fine
map
analysi
pprv
h
antigen
epitop
reveal
exist
sequenc
segment
minim
motif
base
sequenc
comparison
among
differ
pprv
strain
two
motif
conserv
primari
amino
acid
sequenc
align
hemagglutinin
member
genu
morbilliviru
indic
type
ii
membran
glycoprotein
h
protein
compris
ntermin
cytoplasm
tail
aa
transmembran
region
aa
stalk
region
aa
ctermin
receptorbind
head
domain
aa
terminu
colf
et
al
hashiguchi
et
al
accordingli
two
conserv
motif
shown
fig
locat
ntermin
cytoplasm
tail
head
domain
respect
three
eleven
nonconserv
motif
locat
within
stalk
region
remain
eight
motif
locat
within
ctermin
head
domain
expect
antigen
motif
locat
within
transmembran
region
lack
reactiv
epitop
contain
minim
epitop
respect
antipprv
serum
consist
predict
deepseat
locat
within
h
protein
howev
failur
goat
antipprv
serum
react
epitop
contain
minim
epitop
respect
predict
locat
surfac
h
protein
fig
unexpect
possibl
predict
surfac
locat
epitop
incorrect
sinc
crystal
structur
data
relat
cytoplasm
tail
stalk
region
morbillivirus
would
allow
predict
structur
high
confid
also
possibl
epitop
fail
induc
immun
respons
host
sinc
former
enclos
intact
viru
particl
latter
may
buri
tetramer
h
protein
complex
format
fusion
machineri
although
minim
b
cell
epitop
normal
rang
amino
acid
long
improv
methodolog
employ
fine
map
linear
b
cell
epitop
pprv
n
protein
identifi
two
epitop
etp
llg
yu
et
al
earlier
xu
et
al
identifi
epitop
egp
map
minim
motif
bcell
epitop
human
zona
pellucida
recent
studi
decod
iggepitom
protein
oncogen
human
papillomaviru
type
xu
et
al
structur
model
cytoplasm
tail
region
stalk
region
b
head
domain
cf
pprv
h
protein
predict
http
wwwsbgbioicac
idindex
use
intens
model
visual
use
pymol
molecular
graphic
model
system
f
e
except
color
share
residu
v
marin
color
bce
e
wheat
color
bce
f
bce
minim
motif
identifi
studi
highlight
differ
color
red
split
pea
blue
hot
pink
warm
pink
lemon
marin
wheat
pink
cyan
orang
magenta
pale
green
r
yu
et
al
veterinari
microbiolog
also
identifi
epitop
sap
protein
cell
entri
envelop
virus
involv
viru
attach
follow
close
apposit
fusion
virion
cell
membran
although
less
research
work
focus
precis
mechan
pprv
cell
entri
studi
member
morbilliviru
especi
mev
indic
fusion
machineri
compos
heterooligomer
complex
form
tetramer
attach
h
trimer
fusion
f
glycoprotein
plattet
et
al
head
domain
h
protein
recogn
bind
multipl
receptor
compel
function
biochem
evid
indic
stalk
region
predominantli
involv
interact
f
protein
grow
bodi
evid
suggest
engag
hhead
cognat
receptor
caus
structur
rearrang
within
hstalk
section
strict
requir
trigger
f
refold
cascad
factiv
necessari
achiev
membran
fusion
corey
iorio
plattet
et
al
trigger
fusion
machineri
turn
essenti
initi
morbilliviru
infect
novel
antivir
could
develop
specif
target
receptorbind
site
imped
receptor
interact
microdomain
within
head
andor
stalk
domain
therebi
prevent
conform
chang
evok
f
activ
conceptu
support
use
stalk
domain
h
protein
potenti
drug
target
plattet
plemper
report
mab
recogn
linear
epitop
cdv
h
stalk
domain
act
potent
inhibitor
membran
fusion
plattet
plemper
three
bce
motif
rlntnikl
idhqt
iigdevgiri
correspond
respect
identifi
pprv
hstalk
region
latter
two
predict
surfac
expos
recogniz
goat
antipprv
serum
fig
theoret
bce
motif
also
consid
candid
design
pprv
antibodybas
drug
multiepitop
vaccin
recent
complex
head
domain
mev
h
highli
homolog
pprv
h
receptor
slam
disclos
hashiguchi
et
al
santiago
et
al
zhang
et
al
combin
slam
receptor
follow
residu
mev
h
involv
pro
gli
ly
gln
pro
met
leu
gli
leu
phe
val
thr
leu
glu
asp
asp
tyr
leu
thr
asp
val
tyr
tyr
arg
elucid
interact
mev
h
receptor
provid
ideal
templat
homolog
model
member
genu
morbilliviru
homolog
model
compar
interact
energi
data
indic
pprv
hsheep
slam
bind
interfac
mev
hmarmoset
slam
bind
interfac
consist
liang
et
al
base
observ
four
linear
bce
motif
identifi
herein
veacktr
flgmint
vmphilt
vdddik
respect
locat
receptor
bind
pocket
pprv
h
veacktr
vmphilt
vdddik
could
recogn
goat
antipprv
serum
fig
previou
research
antigen
epitop
mev
h
show
major
mev
h
monoclon
antibodi
neutral
capabl
target
receptorbind
area
hashiguchi
et
al
tahara
et
al
accordingli
tempt
anticip
three
bce
motif
potenti
use
candid
pprv
multiepitop
vaccin
develop
serolog
crossreact
among
morbillivirus
eg
pprv
rpv
one
main
constraint
achiev
reliabl
diagnos
among
surfac
protein
h
protein
induc
littl
crossreact
virus
genu
libeau
comparison
amino
acid
sequenc
rpv
pprv
h
protein
indic
similar
munir
et
al
r
yu
et
al
veterinari
microbiolog
littl
known
locat
bce
mab
combin
research
sequenc
align
indic
sequenc
motif
rpv
h
protein
ident
minim
motif
epitop
found
pprv
h
protein
clearli
identif
pprv
specif
linear
bce
motif
includ
two
conserv
bce
motif
h
protein
signific
establish
pprv
differenti
diagnos
although
specif
yet
valid
experiment
facilit
postoutbreak
serosurveil
pprv
erad
local
veterinarian
endem
area
made
strong
call
marker
vaccin
companion
test
differenti
infect
vaccin
anim
diva
project
recent
banyard
group
develop
novel
strategi
construct
morbilliviru
marker
vaccin
mutat
specif
mab
bind
site
rpv
pprv
h
protein
render
vaccin
viru
undetect
mab
buczkowski
et
al
muniraju
et
al
tandem
chelisa
allow
differenti
vaccin
natur
infect
anim
clearli
identif
minim
motif
linear
bce
motif
pprv
h
provid
addit
candid
epitop
antigen
data
develop
pprv
diva
vaccin
conclus
biosynthet
peptid
use
identifi
linear
bce
minim
motif
pprv
protein
includ
two
motif
conserv
pprv
strain
nine
peptid
contain
one
identifi
bce
motif
react
goat
antipprv
serum
identif
bce
motif
elucid
antigen
characterist
h
protein
provid
solid
foundat
understand
natur
immun
pprv
develop
epitopebas
surveil
vaccin
